New research advances genetic diagnosisDemonstrates the potential to expand equitable access to treatment for patients living with rare inherited metabolic and neurodegenerative diseasesBALTIMORE ...
Oryzon Genomics SA (ES:ORY) has released an update. Oryzon Genomics has reported a reduction in R&D investments and a slight increase in revenue from its own assets for Q3 2024, despite a net loss of ...
Building on that foundation, the GO Genomic Report generated through this workflow will now include a direct link to the WeTrials platform. With a single click, clinicians can move from a patient's ...
A narrative review examines how generative AI tools such as large language models and vision-language models could assist precision oncology by interpreting genomic data, matching patients to clinical ...
SAN FRANCISCO--(BUSINESS WIRE)--Stanford University and Cofactor Genomics, the company bridging the precision medicine gap, announced today that Stanford will join Cofactor’s PREDAPT (Predicting ...
Patient-centered education and navigation support increase consent rates for genomic testing, aiding integration into cancer care and access to genomics-based trials. The SURGE study underscores the ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today ...
Comparison of surgical procedures and short- and mid-term outcomes for transverse colon cancer: A retrospective study from a single center. A novel framework to grade the quality of surrogate ...
Worldwide clinical PERIBLOOD™ trial by the Weizmann Institute to evaluate single cell RNA sequencing from blood as a Non-Invasive Path for Blood Disorder Diagnosis, complementing bone marrow ...
StockStory.org on MSN
Life sciences tools & services stocks Q4 in review: 10x Genomics (NASDAQ:TXG) vs peers
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including ...
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results